Skip to Content
Authors Kennedy G, Komano J, Sugden B
Journal Proc. Natl. Acad. Sci. U.S.A. Volume: 100 Issue: 24 Pages: 14269-74
Publish Date 2003 Nov 25
PubMed ID 14603034
PMC ID 283581

Epstein-Barr virus (EBV) has been causally associated with at least five human malignancies. The exact contributions made by EBV to these cancers remain unknown. We demonstrate that one viral protein found in all EBV-associated malignancies, Epstein-Barr nuclear antigen 1 (EBNA-1), is required for survival of one of these cancers, EBV-positive Burkitt’s lymphoma. Inhibition of EBNA-1 decreases survival of these tumor cells by inducing apoptosis. Expression of EBNA-1 in uninfected cells also can inhibit apoptosis induced by expression of p53 in the absence of the EBV genome. Our findings demonstrate that EBNA-1 is critical for the continued survival of EBV-associated Burkitt’s lymphoma, and, by extension, for the other B cell tumors with which EBV is associated. Efficient inhibitors of EBNA-1’s functions would likely prove useful in the therapy of EBV-associated malignancies.

Full Text Full text available on PubMed Central Copyright © 2017 The Board of Regents of the University of Wisconsin System